These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35012841)

  • 21. Estimation of serum calcium levels in apheresis platelet donors.
    Arpitha P; Thokala RP
    Asian J Transfus Sci; 2024; 18(1):62-66. PubMed ID: 39036698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary citrate and plasma ionized calcium: Implications for platelet donors.
    Haynes S; Hickson E; Linden J; St Pierre P; Ducharme P; Sulmasy P; Welch L; Zhao Y; Greene M; Vauthrin M; Weinstein R
    J Clin Apher; 2018 Jun; 33(3):222-225. PubMed ID: 28802068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of physical symptoms, ECG, free calcium, and other blood chemistries in reinfusion with citrated blood.
    Ladenson JH; Miller WV; Sherman LA
    Transfusion; 1978; 18(6):670-9. PubMed ID: 31718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of plateletapheresis with two continuous-flow cell separators using identical donors.
    Mintz PD
    Transfusion; 1985; 25(4):330-3. PubMed ID: 4024230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
    Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
    Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
    Morse EE; Hohnadel DC; Genco P; Katz AJ
    Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe citrate toxicity complicating volunteer apheresis platelet donation.
    Bell AM; Nolen JD; Knudson CM; Raife TJ
    J Clin Apher; 2007 Feb; 22(1):15-6. PubMed ID: 17111419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent plateletpheresis donations & its effect on haematological parameters: An observational study.
    Nayak S; Coshic P; Pandey RM; Chatterjee K
    Indian J Med Res; 2019 Nov; 150(5):468-476. PubMed ID: 31939390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of evalution of haematocrit in plateletpheresis donors.
    Mane VB; Jagtap PE; Nagane NS; Dhonde SP; Belwalkar GJ; Mane VP
    J Clin Diagn Res; 2015 Apr; 9(4):BC06-7. PubMed ID: 26023547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QTc prolongation in apheresis platelet donors.
    Laspina SJ; Browne MA; McSweeney EN; Lawlor J; Whelan DM; Kinsella AL; Murphy WG
    Transfusion; 2002 Jul; 42(7):899-903. PubMed ID: 12375663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in hematological parameters post plateletpheresis: Single center study from North India.
    Rajput S; Makroo RN; Chowdhry M; Thakur UK
    Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alarmed or unalarmed!! Donor red cell lysis during plateletpheresis procedure.
    Kaur D; Kandwal M
    Transfus Apher Sci; 2018 Apr; 57(2):277-280. PubMed ID: 29610044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and predictors of adverse reactions in plateletpheresis donors with the perspective of donor safety in a tertiary care hospital of Northern India.
    Solanki A; Katharia R; Singh A; Chauhan A; Chandra T; Sonker A; Agarwal P
    Asian J Transfus Sci; 2020; 14(1):44-48. PubMed ID: 33162705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective cell support by repeat plateletpheresis of related donors on the IBM 2997 cell separator.
    Langley JW; Spiva D; Hendren D; Orrell J
    Am J Clin Pathol; 1981 Aug; 76(2):148-54. PubMed ID: 7270495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapheresis.
    Toffaletti J; Nissenson R; Endres D; McGarry E; Mogollon G
    J Clin Endocrinol Metab; 1985 May; 60(5):874-9. PubMed ID: 3980672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to stabilize the level of ionized calcium and citrate during plateletpheresis.
    Farrokhi P; Farahmand H; Bismuth A; Suarez C; Ducot B; Gillon MC; Debat P; Laskowski P; Pinon F
    Vox Sang; 1998; 74(1):7-12. PubMed ID: 9481853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in protein-bound, complex-bound, and ionized calcium related to parathyroid hormone levels in healthy donors during plateletapheresis.
    Toffaletti J
    Transfusion; 1983; 23(6):471-5. PubMed ID: 6649022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in endogenous thrombopoietin in healthy donors after automated plateletpheresis.
    Dettke M; Hlousek M; Kurz M; Leitner G; Rosskopf K; Stiegler G; Stohlawetz P; Worel N; Höcker P; Panzer S
    Transfusion; 1998 May; 38(5):449-53. PubMed ID: 9633557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.